Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
Douglas B. Johnson(Vanderbilt University Medical Center), Matthew D. Tucker(University of Alabama at Birmingham), Lisa B. Weissman(Mount Auburn Hospital), Anup Kasi(University of Kansas Medical Center), Brandon Hayes‐Lattin(Oregon Health & Science University), Kendra Viera(Brown University), Dimitrios Farmakiotis(Brown University), Daniel Flora(St. Elizabeth Healthcare), James J. Yoon(University of Michigan), Alaina J. Brown(Vanderbilt University Medical Center), Carmen C. Solórzano(Vanderbilt University Medical Center), Leslie A. Fecher(University of Pennsylvania), Saqib Hussen Abbasi(The University of Kansas Cancer Center), Cecilia A. Castellano(Emory University), Ziad Bakouny(Dana-Farber Cancer Institute), Chinmay Jani(Mount Auburn Hospital), Sonya Reid(Vanderbilt University), Joy Awosika(University of Cincinnati), Alicia Beeghly‐Fadiel(Vanderbilt University Medical Center), Nino Balanchivadze(Henry Ford Hospital), Jeremy L. Warner(Brown University), David Slosky(Jisc), Hannah Heilman(University of Cincinnati), Clara Hwang(Henry Ford Health System), Mehmet Asım Bilen(Emory Healthcare), Elizabeth J. Klein(Brown University), Renée Maria Saliby(Yale University), Michael B. Atkins(Georgetown University), Benjamin French(Vanderbilt University Medical Center), Sanjay Mishra(Vanderbilt University Medical Center), Trisha M. Wise‐Draper(University of Cincinnati), Daniel Y. Reuben(Medical University of South Carolina), Catherine C. Fahey(University of North Carolina at Chapel Hill), Elizabeth Wulff‐Burchfield(University of Kansas Medical Center), Alex Cheng, Christopher R. Friese(University of Michigan), Elizabeth J. Davis(Vanderbilt University Medical Center), Lisa Tachiki(University of Washington), Gary H. Lyman(University of Washington), Matthew Puc(Virtua Health), Xuanyi Li(Vanderbilt University), Sunny Singh(Henry Ford Hospital), Sumit Shah(Palo Alto University), Kyle T. Enriquez, Daniel Hausrath(Medical University of South Carolina), Sarah Croessmann(Vanderbilt University), Michael Glover(Stanford University), Erin A. Gillaspie(Vanderbilt University Medical Center), Cassandra Hennessy(Vanderbilt University Medical Center), Chris Labaki(Beth Israel Deaconess Medical Center)
Cited by 2
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k